Heme-binding protein (HEBP) (HEBP)

Heme-binding proteins (HEBPs) are a specialized class of intracellular proteins, including HEBP1 and HEBP2, that facilitate the transport and sequestration of heme and its precursors (UniProt: P45591). These proteins are essential for maintaining cellular heme homeostasis and preventing the oxidative damage caused by unbound, free heme (PubMed: 21454485). HEBP1, the most well-characterized member, binds protoporphyrin IX and heme in the cytosol and is involved in the regulation of the mitochondrial permeability transition pore (PubMed: 33053375). In clinical research, HEBP1 has emerged as a significant factor in Alzheimer's disease, where its upregulation in neurons is linked to amyloid-beta-induced cytotoxicity and apoptosis (PubMed: 33053375). HEBP2, or SOUL, plays a distinct role in promoting necrotic cell death, particularly in response to oxidative stress in various tissues (PubMed: 21454485). Therapeutic interventions targeting HEBPs aim to modulate their binding capacity or prevent their involvement in pathological cell death pathways. Drugs such as hemin and various metalloporphyrins interact with these proteins to manage conditions like porphyria or to study heme-mediated signaling (StatPearls: Heme Synthesis). However, targeting HEBPs presents challenges, as drugs must be highly selective to avoid disrupting the function of essential hemoproteins like hemoglobin and mitochondrial cytochromes (PubMed: 15661706).

Other names

HBPp22HBPHeme-binding protein 1Heme-binding protein 2SOUL protein family

Drugs typically act by mimicking heme to inhibit binding, sequestering free heme to prevent oxidative damage, or modulating the protein's interaction with the mitochondrial permeability transition pore to regulate cell death.